Hypertension in diabetes study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients

Journal of Hypertension

Volumn 11, Issue 3, 1993, Pages 319-325

[No Author Info available]

Author keywords

Cardiovascular disease; Complications; Hypertension; Type 2 diabetes; UK Prospective Diabetes Study

Indexed keywords

ALBUMIN;

ADULT; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; DIABETIC RETINOPATHY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; STROKE;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; DIABETIC ANGIOPATHIES; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMAN; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGE; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0027154921     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/00004872-199303000-00013     Document Type: Article

References (29)

1. United Kingdom Prospective Diabetes Study: III. Prevalence of Hypertension and hypotensive therapy in patients with newly diagnosed diabetes. Hypertension 1985, 7 (suppl 10):118–1113.
2. The Hypertension in Diabetes Study Group: Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens 1993, 11:309–317.
3. Standl E, Stiegler H, Roth R, Schulz K, Lehmacher W: On the impact of hypertension on the prognosis of NIDDM: results of the Schwabing GP-Program. Diabete Metab 1989, 15:352–358.
4. Pell S, D'Alonzo A: Some aspects of hypertension in diabetes mellitus. JAMA 1967, 202:104–110.
5. Pell S, D’Alonzo A: Factors associated with long-term survival of diabetics. JAMA 1970, 214:1833–1840.
6. Goodkin G: Mortality factors in diabetes: a 20 year mortality study. J Occup Med 1975, 17:716–721.
7. Fuller JH: Coronary heart disease risk and impaired glucose tolerance: the Whitehall Study. Lancet 1980, i:373–1376.
8. Rosergen A, Welin L, Tsipogianni A, Wilhelmsen L: Impact of cardiovascular risk factors on coronary heart disease among middle aged diabetic men: a general population study. BMJ 1989, 299:1127–1131.
9. Stamler J, Vaccaro O, Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group: Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care in press.
10. Kannel WB, McGee DL: Diabetes and cardiovascular risk factors: the Framingham Study. Circulation 1979, 59:8–13.
11. The World Health Organization Multinational Study of Vascular Disease in Diabetics: Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. Diabetologia 1985, 28:615–640.
12. UK Prospective Diabetes Study: VIII. Study design, progress and performance. Diabetologia 1991, 34:877–890.
13. Wright BM, Dore CF: A random-zero sphygmomanometer. Lancet 1970, i:33–35.
14. World Health Organization.: International Classification of Procedures in Medicine. Geneva: World Health Organization; 1978.
15. Gatling W, Knight C, Mullee MA, Hill RD: Microalbumin-uria in diabetes: a population study of the prevalence and an assessment of three screening tests. Diabetic Med 1987, 5:343–347.
16. Davis MD, Hubbard LD, Trautman J, Klein R: Conference on insulin pump therapy in diabetes. Multicentre study effect on microvascular disease. Studies of retinopathy: methodology for assessment and classification with fundus photographs. Diabetes 1985, 34 (suppl 3):42–49.
17. Rose GA, Blackburn H, Gillum RF, Prineas RJ: Cardiovascular Survey Methods, 2nd edn. Geneva: World Health Organization; 1982.
18. Peto R, Pike MC, Armitage R, Breslow NE, Cox DR, Howard SV, et al: Design and analysis of randomised clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer 1977, 35:1–38.
19. SAS Institute: Statistical Analysis System, version 6. Cary, North Carolina: SAS Institute; 1990.
20. Dixon WJ (ed): BMDP Statistical Software. Berkeley, California: University of California Press; 1981.
21. Jarrett RJ, Shipley MJ: Mortality and associated risk factors in diabetics. Acta Endocrinol 1985, suppl 272:21–26.
22. MacMahon S, Peto R, Cutler J, Collins R, Sortie P, Neaton J, et al.: Blood pressure, stroke and coronary heart disease: part I, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990, 335:765–774.
23. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al: Blood pressure, stroke, and coronary heart disease: part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemi-ological context. Lancet 1990, 335:827–838.
24. Chobanian AV: Antihypertensive therapy in evolution. N Engl J Med 1986, 314:1701–1702.
25. Practical aspects of blood pressure management. Drugs Ther Bull 1991, 29:53–55.
26. Working Group of Hypertension in Diabetes: Statement on hypertension in diabetes mellitus: final report. Arch Intern Med 1987, 147:830–842.
27. Fabre J, Balant LP, Dayer PG, Fox HM, Vernet AT: The kidney in maturity onset diabetes mellitus: a clinical study of 510 patients. Kidney Int 1982, 21:730–738.
28. Teuscher A, Schnell H, Wilson PWF: Incidence of diabetic retinopathy and relationship to baseline plasma glucose and blood pressure. Diabetes Care 1988, 11:246–251.
29. Knowler WC, Bennett PH, Baluntine EJ: Increased incidence of retinopathy in diabetics with elevated blood pressure: a six year follow-up study in Pima indians. N Engl J Med 1980, 302:645–650.